Andy Pasternak - 01 Nov 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role: EVP and Chief Business Officer
Signature: /s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 01 Nov 2022
Net transactions value: -$347,680
Form type: 4
Filing time: 02 Nov 2022, 16:12:33 UTC
Previous filing: 29 Jul 2022
Next filing: 14 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HZNP	Ordinary Shares	Options Exercise		+12,421	+36%		46,468	01 Nov 2022	Direct	F1
transaction	HZNP	Ordinary Shares	Tax liability	$347,680	-5,503	-12%	$63.18	40,965	01 Nov 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HZNP	Restricted Stock Units	Options Exercise	$0	+12,421		$0.000000^*	0	01 Nov 2022	Ordinary shares	12,421		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
F2	The shares subject to the restricted stock units vest in three equal annual installments, beginning November 1, 2020.